Clariscience offers companies a service for preparing Biological Evaluation Plans and Reports, in accordance with the new approach to testing proposed by the 2018 version of ISO10993-1.
The activities envisaged under the service will be managed by a project leader, an expert in regulatory affairs, who will personally take care of the delivery of the consulting, collaborating with a qualified toxicologist.
The service is useful for companies wishing to ensure the biological safety of their medical devices, supported by specialised experts in the field who possess the specific expertise required to conduct this type of evaluation.
